Pan-cancer analysis reveals HMOX1 as a cancer prognosis and immune infiltration-related biomarker
Year: 2025
Type: article
Abstract: experiments demonstrated that HMOX1 knockdown accelerates cell-cycle progression and enhances proliferation and migration in 786-O and Caki-1 cells. Collectively, our findings establish HMOX1 as a promising prognostic biomarker and potential immunotherapeutic target across multiple cancers.
Source: RSC Medicinal Chemistry
DOI: 10.1039/d5md00616c
Authors: Yingli Men, Hui Wang, Xiaoyan Xu, Miling Yang, Ruiting Feng, Jizhi Zhao, Ying Liu, Lu Yang, Yinsen Song, Cong Ding
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G2707610427, G3157851467, G7146641154
OpenAlex ID: W4414609164
